Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.1K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.1K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.8K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.8K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

719
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
719
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

592
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
592
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

1.2K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.2K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

3.2K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
3.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Third exposure to COVID-19 infection or vaccination differentially impacts T cell responses.

The Journal of infection·2025
Same author

What it takes to become a physician scientist in a low- and middle-income country.

PLOS global public health·2025
Same author

Derivation of a high-resolution CT-based, semi-automated radiographic score in tuberculosis and its relationship to bacillary load and antitubercular therapy.

The European respiratory journal·2023
Same author

Blood and Site of Disease Inflammatory Profiles Differ in Patients With Pericardial Tuberculosis and Human Immunodeficiency Virus Type 1.

Open forum infectious diseases·2023
Same author

Corrigendum: Comparison of the frequency and phenotypic profile of <i>Mycobacterium tuberculosis</i>-specific CD4 T cells between the site of disease and blood in pericardial tuberculosis.

Frontiers in immunology·2023
Same author

Phenotypic Profile of <i>Mycobacterium tuberculosis</i>-Specific CD4 T-Cell Responses in People With Advanced Human Immunodeficiency Virus Who Develop Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome.

Open forum infectious diseases·2023

Related Experiment Video

Updated: Mar 8, 2026

An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei
09:02

An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei

Published on: February 17, 2014

20.3K

The Immune Interaction between HIV-1 Infection and Mycobacterium tuberculosis.

Elsa Du Bruyn1, Robert John Wilkinson1,2

  • 1Clinical Infectious Diseases Research Initiative, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Observatory 7925, Republic of South Africa.

Microbiology Spectrum
|January 14, 2017
PubMed
Summary
This summary is machine-generated.

Human immunodeficiency virus (HIV) and tuberculosis (TB) coinfection accelerates disease. While antiretroviral therapy (ART) reduces TB risk, immune reconstitution inflammatory syndrome (IRIS) remains a concern in HIV-TB patients.

More Related Videos

Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1
07:42

Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1

Published on: February 28, 2025

995
An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection
08:14

An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection

Published on: October 6, 2015

10.7K

Related Experiment Videos

Last Updated: Mar 8, 2026

An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei
09:02

An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei

Published on: February 17, 2014

20.3K
Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1
07:42

Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1

Published on: February 28, 2025

995
An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection
08:14

An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection

Published on: October 6, 2015

10.7K

Area of Science:

  • Infectious Diseases
  • Immunology
  • Public Health

Background:

  • Human immunodeficiency virus (HIV)-1 coinfection significantly alters tuberculosis (TB) natural history, presentation, and prognosis.
  • The "deadly syndemic" of HIV-1 and TB involves mutual replication, increasing morbidity and mortality.
  • HIV-1 is a major risk factor for active TB, accounting for 13% of global cases.

Purpose of the Study:

  • To elucidate the complex interplay between HIV-1 and TB immunopathology.
  • To understand how antiretroviral therapy (ART) impacts the HIV-TB syndemic.
  • To highlight the ongoing challenges posed by immune reconstitution inflammatory syndrome (IRIS) in coinfected patients.

Main Methods:

  • Review of existing literature on HIV-1 and TB coinfection.
  • Analysis of the impact of combination antiretroviral therapy (ART) on TB incidence.
  • Examination of the mechanisms underlying immune reconstitution inflammatory syndrome (IRIS) in HIV-TB patients.

Main Results:

  • Combination antiretroviral therapy (ART) has substantially reduced the risk of TB in HIV-1 patients.
  • Despite ART, HIV-1 patients remain at increased risk for TB, especially in high-incidence settings.
  • ART-induced immune recovery can paradoxically lead to IRIS, particularly in lower CD4 count strata.

Conclusions:

  • ART is crucial in mitigating the HIV-TB syndemic, but does not eliminate TB risk.
  • Immune reconstitution inflammatory syndrome (IRIS) remains a significant clinical challenge in managing HIV-TB coinfection.
  • Further research is needed to optimize management strategies for the HIV-TB syndemic, addressing both infection control and IRIS prevention.